Gender Differences in Human Sepsis
BACKGROUND In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to sepsis in males. OBJECTIVE In a prospective study, gender differences in patients with surgical sepsis were evaluated in terms of survival, sex h...
Saved in:
Published in | Archives of surgery (Chicago. 1960) Vol. 133; no. 11; pp. 1200 - 1205 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Medical Association
01.11.1998
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | BACKGROUND In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to sepsis in males. OBJECTIVE In a prospective study, gender differences in patients with surgical sepsis were evaluated in terms of survival, sex hormones, and proinflammatory as well as anti-inflammatory mediators. SETTING Surgical intensive care unit of a university hospital. PATIENTS Fifty-two patients (19 women and 33 men) with surgical sepsis. MEASUREMENTS AND MAIN RESULTS In a prospective study, tumor necrosis factor α and interleukin 6 bioactivity and plasma levels of interleukin 10 (using enzyme-linked immunosorbent assay), total testosterone, and 17-β estradiol (using radioimmunoassay) were determined on days 1, 3, 5, 7, 10, and 14 after diagnosis of sepsis. There were no differences in characteristics of patients in age (mean age, 55.4 years for women and 53.1 years for men) or cause and severity of sepsis (Acute Physiology and Chronic Health Evaluation II score, 17.3 for women and 18.5 for men; multiple organ dysfunction score, 9.9 vs 10.8, respectively). Although no difference could be found in the multiple organ dysfunction score from day 1 to day 28, the prognosis of sepsis was significantly different in women compared with men. Hospital mortality rate was 70% (23 of 33 patients) in male and 26% (5 of 19) in female patients (P<.008, log-rank test). Bioactivity of tumor necrosis factor continuously increased in men after diagnosis of sepsis, with significantly elevated levels on day 10 (P<.05, Mann-Whitney U test with Bonferroni correction), whereas no difference was found for interleukin 6 bioactivity. Women displayed enhanced interleukin 10 levels compared with men from day 1 to day 10 that reached a significant difference on days 3 and 5 (P<.05). Total testosterone levels were below the normal range for men, and estradiol levels were initially increased in both men and postmenopausal women, with higher levels for women. CONCLUSIONS In this prospective study, gender differences were confirmed in human sepsis, with a significantly better prognosis for women, which may be related to increased levels of anti-inflammatory mediators. The hypothetical different ratio of proinflammatory and anti-inflammatory mediators may be important for further therapeutic interventions in sepsis.--> |
---|---|
AbstractList | BACKGROUNDIn animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to sepsis in males.OBJECTIVEIn a prospective study, gender differences in patients with surgical sepsis were evaluated in terms of survival, sex hormones, and proinflammatory as well as anti-inflammatory mediators.SETTINGSurgical intensive care unit of a university hospital.PATIENTSFifty-two patients (19 women and 33 men) with surgical sepsis.MEASUREMENTS AND MAIN RESULTSIn a prospective study, tumor necrosis factor alpha and interleukin 6 bioactivity and plasma levels of interleukin 10 (using enzyme-linked immunosorbent assay), total testosterone, and 17-beta estradiol (using radioimmunoassay) were determined on days 1, 3, 5, 7, 10, and 14 after diagnosis of sepsis. There were no differences in characteristics of patients in age (mean age, 55.4 years for women and 53.1 years for men) or cause and severity of sepsis (Acute Physiology and Chronic Health Evaluation II score, 17.3 for women and 18.5 for men; multiple organ dysfunction score, 9.9 vs 10.8, respectively). Although no difference could be found in the multiple organ dysfunction score from day 1 to day 28, the prognosis of sepsis was significantly different in women compared with men. Hospital-mortality rate was 70% (23 of 33 patients) in male and 26% (5 of 19) in female patients (P<.008, log-rank test). Bioactivity of tumor necrosis factor continuously increased in men after diagnosis of sepsis, with significantly elevated levels on day 10 (P<.05, Mann-Whitney U test with Bonferroni correction), whereas no difference was found for interleukin 6 bioactivity. Women displayed enhanced interleukin 10 levels compared with men from day 1 to day 10 that reached a significant difference on days 3 and 5 (P<.05). Total testosterone levels were below the normal range for men, and estradiol levels were initially increased in both men and postmenopausal women, with higher levels for women.CONCLUSIONSIn this prospective study, gender differences were confirmed in human sepsis, with a significantly better prognosis for women, which may be related to increased levels of anti-inflammatory mediators. The hypothetical different ratio of proinflammatory and anti-inflammatory mediators may be important for further therapeutic interventions in sepsis. In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to sepsis in males. In a prospective study, gender differences in patients with surgical sepsis were evaluated in terms of survival, sex hormones, and proinflammatory as well as anti-inflammatory mediators. Surgical intensive care unit of a university hospital. Fifty-two patients (19 women and 33 men) with surgical sepsis. In a prospective study, tumor necrosis factor alpha and interleukin 6 bioactivity and plasma levels of interleukin 10 (using enzyme-linked immunosorbent assay), total testosterone, and 17-beta estradiol (using radioimmunoassay) were determined on days 1, 3, 5, 7, 10, and 14 after diagnosis of sepsis. There were no differences in characteristics of patients in age (mean age, 55.4 years for women and 53.1 years for men) or cause and severity of sepsis (Acute Physiology and Chronic Health Evaluation II score, 17.3 for women and 18.5 for men; multiple organ dysfunction score, 9.9 vs 10.8, respectively). Although no difference could be found in the multiple organ dysfunction score from day 1 to day 28, the prognosis of sepsis was significantly different in women compared with men. Hospital-mortality rate was 70% (23 of 33 patients) in male and 26% (5 of 19) in female patients (P<.008, log-rank test). Bioactivity of tumor necrosis factor continuously increased in men after diagnosis of sepsis, with significantly elevated levels on day 10 (P<.05, Mann-Whitney U test with Bonferroni correction), whereas no difference was found for interleukin 6 bioactivity. Women displayed enhanced interleukin 10 levels compared with men from day 1 to day 10 that reached a significant difference on days 3 and 5 (P<.05). Total testosterone levels were below the normal range for men, and estradiol levels were initially increased in both men and postmenopausal women, with higher levels for women. In this prospective study, gender differences were confirmed in human sepsis, with a significantly better prognosis for women, which may be related to increased levels of anti-inflammatory mediators. The hypothetical different ratio of proinflammatory and anti-inflammatory mediators may be important for further therapeutic interventions in sepsis. BACKGROUND: In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to sepsis in males. OBJECTIVE: In a prospective study, gender differences in patients with surgical sepsis were evaluated in terms of survival, sex hormones, and proinflammatory as well as anti-inflammatory mediators. SETTING: Surgical intensive care unit of a university hospital. PATIENTS: Fifty-two patients (19 women and 33 men) with surgical sepsis. MEASUREMENTS AND MAIN RESULTS: In a prospective study, tumor necrosis factor alpha and interleukin 6 bioactivity and plasma levels of interleukin 10 (using enzyme-linked immunosorbent assay), total testosterone, and 17-beta estradiol (using radioimmunoassay) were determined on days 1, 3, 5, 7, 10, and 14 after diagnosis of sepsis. There were no differences in characteristics of patients in age (mean age, 55.4 years for women and 53.1 years for men) or cause and severity of sepsis (Acute Physiology and Chronic Health Evaluation II score, 17.3 for women and 18.5 for men; multiple organ dysfunction score, 9.9 vs 10.8, respectively). Although no difference could be found in the multiple organ dysfunction score from day 1 to day 28, the prognosis of sepsis was significantly different in women compared with men. Hospital-mortality rate was 70% (23 of 33 patients) in male and 26% (5 of 19) in female patients (P<.008, log-rank test). Bioactivity of tumor necrosis factor continuously increased in men after diagnosis of sepsis, with significantly elevated levels on day 10 (P<.05, Mann-Whitney U test with Bonferroni correction), whereas no difference was found for interleukin 6 bioactivity. Women displayed enhanced interleukin 10 levels compared with men from day 1 to day 10 that reached a significant difference on days 3 and 5 (P<.05). Total testosterone levels were below the normal range for men, and estradiol levels were initially increased in both men and postmenopausal women, with higher levels for women. CONCLUSIONS: In this prospective study, gender differences were confirmed in human sepsis, with a significantly better prognosis for women, which may be related to increased levels of anti-inflammatory mediators. The hypothetical different ratio of proinflammatory and anti-inflammatory mediators may be important for further therapeutic interventions in sepsis. BACKGROUND In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to sepsis in males. OBJECTIVE In a prospective study, gender differences in patients with surgical sepsis were evaluated in terms of survival, sex hormones, and proinflammatory as well as anti-inflammatory mediators. SETTING Surgical intensive care unit of a university hospital. PATIENTS Fifty-two patients (19 women and 33 men) with surgical sepsis. MEASUREMENTS AND MAIN RESULTS In a prospective study, tumor necrosis factor α and interleukin 6 bioactivity and plasma levels of interleukin 10 (using enzyme-linked immunosorbent assay), total testosterone, and 17-β estradiol (using radioimmunoassay) were determined on days 1, 3, 5, 7, 10, and 14 after diagnosis of sepsis. There were no differences in characteristics of patients in age (mean age, 55.4 years for women and 53.1 years for men) or cause and severity of sepsis (Acute Physiology and Chronic Health Evaluation II score, 17.3 for women and 18.5 for men; multiple organ dysfunction score, 9.9 vs 10.8, respectively). Although no difference could be found in the multiple organ dysfunction score from day 1 to day 28, the prognosis of sepsis was significantly different in women compared with men. Hospital mortality rate was 70% (23 of 33 patients) in male and 26% (5 of 19) in female patients (P<.008, log-rank test). Bioactivity of tumor necrosis factor continuously increased in men after diagnosis of sepsis, with significantly elevated levels on day 10 (P<.05, Mann-Whitney U test with Bonferroni correction), whereas no difference was found for interleukin 6 bioactivity. Women displayed enhanced interleukin 10 levels compared with men from day 1 to day 10 that reached a significant difference on days 3 and 5 (P<.05). Total testosterone levels were below the normal range for men, and estradiol levels were initially increased in both men and postmenopausal women, with higher levels for women. CONCLUSIONS In this prospective study, gender differences were confirmed in human sepsis, with a significantly better prognosis for women, which may be related to increased levels of anti-inflammatory mediators. The hypothetical different ratio of proinflammatory and anti-inflammatory mediators may be important for further therapeutic interventions in sepsis.--> |
Author | Stüber, Frank Staubach, Karl-Hermann Zabel, Peter Schröder, Jörg Kahlke, Volker |
Author_xml | – sequence: 1 givenname: Jörg surname: Schröder fullname: Schröder, Jörg – sequence: 2 givenname: Volker surname: Kahlke fullname: Kahlke, Volker – sequence: 3 givenname: Karl-Hermann surname: Staubach fullname: Staubach, Karl-Hermann – sequence: 4 givenname: Peter surname: Zabel fullname: Zabel, Peter – sequence: 5 givenname: Frank surname: Stüber fullname: Stüber, Frank |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/9820351$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkE1LAzEQhoNUalv9AYLC0oO3XTP52CRHqdoKBQ_2HtLdRLd0szXpHvz3prT24GkG3ucdhmeMBr7zFqE7wAVgDI8mVF-xD58FUFoAFEAwvkAj4FTmtGRsgEYYY5YnFl-hcYybtBGpyBANlSSYchih6dz62obsuXHOBusrG7PGZ4u-NT77sLvYxGt06cw22pvTnKDV68tqtsiX7_O32dMyN1TRfQ51xY2DShJlS1JzxlRaOK6ZIap2kouydJjXXDq1pkKtLSO2qoThqcExnaCH49ld6L57G_e6bWJlt1vjbddHLTAWTFBI4PQfuOn64NNrmlDCuRBSJIgdoSp0MQbr9C40rQk_GrA-6NN_-nTSpwH0QV-q3Z9u9-vW1ufSyVfKb4-5ac05JACSSvoLiBl0kA |
CitedBy_id | crossref_primary_10_4161_viru_26982 crossref_primary_10_1016_j_steroids_2024_109426 crossref_primary_10_1080_07853890_2023_2244873 crossref_primary_10_1007_s10620_017_4554_6 crossref_primary_10_1124_jpet_105_090480 crossref_primary_10_1152_ajpendo_00279_2017 crossref_primary_10_1038_s41590_018_0211_2 crossref_primary_10_1016_S0303_7207_02_00106_5 crossref_primary_10_1016_j_neuroscience_2018_12_008 crossref_primary_10_3389_fpubh_2023_1235745 crossref_primary_10_1016_j_yhbeh_2012_02_005 crossref_primary_10_1016_j_jhep_2004_12_026 crossref_primary_10_1155_2010_485306 crossref_primary_10_1186_s41038_017_0093_9 crossref_primary_10_1371_journal_pone_0100631 crossref_primary_10_1097_SHK_0b013e31815c3ea0 crossref_primary_10_1016_j_ejcdt_2015_12_006 crossref_primary_10_1097_00005373_200209000_00007 crossref_primary_10_1111_cmi_13107 crossref_primary_10_1097_00005373_200209000_00006 crossref_primary_10_1016_S0039_6109_05_70084_0 crossref_primary_10_1097_SLA_0b013e3181dcf36e crossref_primary_10_1007_s10096_013_1957_y crossref_primary_10_1089_sur_2008_046 crossref_primary_10_1016_j_tmrv_2012_08_002 crossref_primary_10_1136_bmjopen_2020_040823 crossref_primary_10_3389_fpubh_2023_1143650 crossref_primary_10_1038_sj_bjc_6601099 crossref_primary_10_1097_NCC_0b013e318202520a crossref_primary_10_1089_109629604773860282 crossref_primary_10_3390_jcm9010077 crossref_primary_10_1097_00001432_200006000_00004 crossref_primary_10_1038_s41467_020_19741_6 crossref_primary_10_1186_s13613_021_00807_7 crossref_primary_10_1016_j_domaniend_2011_01_003 crossref_primary_10_1016_j_ejim_2012_10_009 crossref_primary_10_1186_s41038_017_0083_y crossref_primary_10_4049_jimmunol_1003652 crossref_primary_10_1186_s13741_020_00151_7 crossref_primary_10_1111_nicc_12280 crossref_primary_10_1186_s12906_022_03655_5 crossref_primary_10_1016_j_yjmcc_2009_05_002 crossref_primary_10_1007_s00595_007_3508_6 crossref_primary_10_1016_j_ajog_2008_12_032 crossref_primary_10_1164_rccm_200712_1895OC crossref_primary_10_1164_rccm_200611_1712OC crossref_primary_10_4049_jimmunol_1701677 crossref_primary_10_1038_s41598_023_49311_x crossref_primary_10_1016_j_cellimm_2004_08_002 crossref_primary_10_1152_ajpheart_2000_279_3_H1015 crossref_primary_10_1378_chest_07_2001 crossref_primary_10_1097_01_CCM_0000227173_13497_56 crossref_primary_10_1016_S1348_8643_13_00009_8 crossref_primary_10_1164_ajrccm_165_6_2103038 crossref_primary_10_1097_01_CCM_0000278603_18687_4F crossref_primary_10_1152_ajpcell_00091_2022 crossref_primary_10_1590_S0102_86502007000100004 crossref_primary_10_1016_j_jcrc_2019_09_023 crossref_primary_10_4055_cios21110 crossref_primary_10_1378_chest_125_1_203 crossref_primary_10_7759_cureus_9140 crossref_primary_10_18699_SSMJ20240120 crossref_primary_10_1177_0885066617719750 crossref_primary_10_1016_j_bbi_2020_05_037 crossref_primary_10_3390_microorganisms11030746 crossref_primary_10_1097_TA_0b013e31825a789b crossref_primary_10_1177_00031348221087905 crossref_primary_10_1097_01_CCM_0000155991_88802_4D crossref_primary_10_1002_prca_201300048 crossref_primary_10_1097_01_shk_0000148055_12387_15 crossref_primary_10_1016_j_jpeds_2013_04_018 crossref_primary_10_1007_s00108_008_2288_4 crossref_primary_10_1097_01_shk_0000135257_44570_39 crossref_primary_10_1095_biolreprod_110_085167 crossref_primary_10_1371_journal_pone_0213239 crossref_primary_10_1016_j_mce_2010_07_017 crossref_primary_10_1128_iai_00283_22 crossref_primary_10_1016_j_cyto_2003_10_006 crossref_primary_10_1097_00000658_200201000_00014 crossref_primary_10_1016_S1053_0770_00_90010_7 crossref_primary_10_1371_journal_pone_0067736 crossref_primary_10_1016_j_jaci_2009_02_019 crossref_primary_10_1097_SHK_0000000000001717 crossref_primary_10_1371_journal_pntd_0008737 crossref_primary_10_1097_01_BCR_0000225957_01854_EE crossref_primary_10_4049_jimmunol_0903463 crossref_primary_10_3390_cells12071003 crossref_primary_10_1097_00003246_200103000_00015 crossref_primary_10_1097_TA_0b013e3182468989 crossref_primary_10_1359_jbmr_2003_18_12_2231 crossref_primary_10_1097_00005373_200102000_00013 crossref_primary_10_1097_CCM_0000000000003311 crossref_primary_10_1016_j_surg_2014_04_018 crossref_primary_10_1006_cyto_2002_1016 crossref_primary_10_1007_s10753_008_9075_1 crossref_primary_10_1111_prd_12033 crossref_primary_10_1016_S0271_5317_00_00284_0 crossref_primary_10_3390_pathogens12010109 crossref_primary_10_3748_wjg_v27_i28_4504 crossref_primary_10_1146_annurev_pharmtox_010919_023229 crossref_primary_10_1016_j_burns_2004_10_007 crossref_primary_10_3390_nu4030231 crossref_primary_10_1038_s41598_021_02815_w crossref_primary_10_1186_s12610_016_0034_7 crossref_primary_10_1177_1753425917707026 crossref_primary_10_1186_1471_2466_14_128 crossref_primary_10_1189_jlb_0607360 crossref_primary_10_1016_j_steroids_2015_06_016 crossref_primary_10_1016_j_bbrc_2013_10_042 crossref_primary_10_1371_journal_pone_0231374 crossref_primary_10_1586_eci_11_51 crossref_primary_10_1016_j_jtcvs_2014_03_012 crossref_primary_10_1152_ajpheart_00694_2005 crossref_primary_10_1007_s00595_005_3044_1 crossref_primary_10_1016_j_jphs_2022_05_006 crossref_primary_10_1097_01_CCM_0000266534_14262_E8 crossref_primary_10_1111_j_1365_2354_2008_01036_x crossref_primary_10_1016_S0899_9007_01_00588_3 crossref_primary_10_1007_s00392_011_0403_3 crossref_primary_10_1111_j_1399_6576_2005_00759_x crossref_primary_10_1177_000313480006601001 crossref_primary_10_1002_hep_23782 crossref_primary_10_1097_TA_0b013e31823a06ea crossref_primary_10_1189_jlb_70_6_887 crossref_primary_10_1016_j_jvoice_2022_07_024 crossref_primary_10_17221_7481_VETMED crossref_primary_10_1016_j_jss_2005_07_039 crossref_primary_10_1189_jlb_1103589 crossref_primary_10_1097_MCC_0b013e3283307a12 crossref_primary_10_1097_CCM_0b013e3181a569df crossref_primary_10_1016_j_jss_2007_12_777 crossref_primary_10_1172_JCI0215704 crossref_primary_10_1016_j_bbi_2008_10_001 crossref_primary_10_1186_s40001_024_01651_8 crossref_primary_10_1016_S0741_8329_02_00278_1 crossref_primary_10_1007_s00384_013_1647_3 crossref_primary_10_1097_01_CCM_0000261890_41311_E9 crossref_primary_10_1210_endo_143_7_8919 crossref_primary_10_1016_j_genm_2012_10_009 crossref_primary_10_1210_endo_141_4_7404 crossref_primary_10_1016_j_injury_2004_03_014 crossref_primary_10_1016_j_vaccine_2003_10_019 crossref_primary_10_1016_S0899_9007_00_00449_4 crossref_primary_10_3390_ijms21113861 crossref_primary_10_1016_j_jvs_2009_08_006 crossref_primary_10_1016_j_jvoice_2022_11_035 crossref_primary_10_1007_s11605_014_2574_5 crossref_primary_10_1053_j_jvca_2017_04_045 crossref_primary_10_1155_2015_734857 crossref_primary_10_1097_00003246_200301000_00036 crossref_primary_10_1002_glia_22399 crossref_primary_10_3389_fimmu_2021_698121 crossref_primary_10_1097_CCM_0000000000002649 crossref_primary_10_1007_s11739_022_03077_8 crossref_primary_10_1080_10739680600777599 crossref_primary_10_1212_01_CON_0000300029_68650_8f crossref_primary_10_1097_01_TA_0000025584_46870_95 crossref_primary_10_1097_CCE_0000000000000392 crossref_primary_10_1590_S1806_37132011000100013 crossref_primary_10_3109_00365548_2012_760844 crossref_primary_10_1152_ajpheart_00706_2003 crossref_primary_10_1152_ajplung_00337_2020 crossref_primary_10_1186_CC11355 crossref_primary_10_1007_s12016_017_8648_x crossref_primary_10_1097_GME_0000000000000864 crossref_primary_10_1097_01_shk_0000191341_31530_5e crossref_primary_10_1007_s10903_022_01413_w crossref_primary_10_1016_j_jss_2004_04_020 crossref_primary_10_1111_j_1537_2995_2012_03618_x crossref_primary_10_3390_life14050561 crossref_primary_10_1080_23744235_2021_1900906 crossref_primary_10_1113_JP286216 crossref_primary_10_1097_CCM_0b013e31819da853 crossref_primary_10_1016_S1521_6616_02_00025_6 crossref_primary_10_1080_13685530500233847 crossref_primary_10_1371_journal_pone_0281939 crossref_primary_10_1038_s41598_023_27506_6 crossref_primary_10_1097_01_CCM_0000186748_64438_7B crossref_primary_10_1007_s00101_006_0983_x crossref_primary_10_1136_heartjnl_2021_319254 crossref_primary_10_1097_01_shk_0000177639_22863_99 crossref_primary_10_1186_cc12570 crossref_primary_10_1097_SHK_0000000000000226 crossref_primary_10_1007_s00423_002_0346_2 crossref_primary_10_1002_jmv_27075 crossref_primary_10_1007_s12018_018_9253_0 crossref_primary_10_1089_109629603764655263 crossref_primary_10_1016_j_nut_2008_03_015 crossref_primary_10_1152_ajplung_00302_2004 crossref_primary_10_1111_j_1748_1716_2011_02334_x crossref_primary_10_1016_j_bbi_2015_08_013 crossref_primary_10_1089_sur_2023_154 crossref_primary_10_1097_TA_0000000000000251 crossref_primary_10_1002_jnr_23831 crossref_primary_10_1152_ajpcell_2000_278_3_C509 crossref_primary_10_1254_fpj_23040 crossref_primary_10_1097_01_shk_0000239767_64786_de crossref_primary_10_1111_j_1365_277X_2010_01064_x crossref_primary_10_1016_j_athoracsur_2008_02_082 crossref_primary_10_1016_j_surg_2005_03_016 crossref_primary_10_1016_S1550_8579_07_80061_1 crossref_primary_10_1080_00365521_2021_2002927 crossref_primary_10_1039_C5FO01357G crossref_primary_10_1186_s43044_020_0039_6 crossref_primary_10_1080_02688697_2022_2064430 crossref_primary_10_1038_s41598_024_52735_8 crossref_primary_10_1016_j_jcrc_2014_03_021 crossref_primary_10_1016_j_surg_2005_03_020 crossref_primary_10_1016_S0002_9343_01_00771_9 crossref_primary_10_1016_j_metabol_2023_155400 crossref_primary_10_1007_BF03339893 crossref_primary_10_1242_dmm_008052 crossref_primary_10_1186_s13293_015_0035_9 crossref_primary_10_1186_cc13132 crossref_primary_10_1097_01_CCM_0000256839_50053_1D crossref_primary_10_3892_mmr_2015_3394 crossref_primary_10_1152_ajpcell_00467_2004 crossref_primary_10_1177_24705470211032208 crossref_primary_10_1097_CCM_0b013e3181ad7654 crossref_primary_10_1007_s00423_006_0127_4 crossref_primary_10_1016_S0020_1383_02_00018_9 crossref_primary_10_1089_jwh_2013_4434 crossref_primary_10_1111_bph_12063 crossref_primary_10_1097_TA_0b013e31816543dd crossref_primary_10_1159_000073775 crossref_primary_10_1007_s12035_019_01681_y crossref_primary_10_1016_S1885_5857_10_70285_1 crossref_primary_10_1097_SHK_0b013e3181506ee5 crossref_primary_10_1016_j_ejphar_2018_01_051 crossref_primary_10_1016_j_jinf_2022_04_035 crossref_primary_10_1016_j_trsl_2007_12_008 crossref_primary_10_1186_cc1067 crossref_primary_10_1016_j_vetimm_2015_06_009 crossref_primary_10_1186_s13293_018_0187_5 crossref_primary_10_4161_viru_27045 crossref_primary_10_4049_jimmunol_179_9_6284 crossref_primary_10_3389_fimmu_2019_01052 crossref_primary_10_1097_01_ta_0000174941_53688_01 crossref_primary_10_1097_01_shk_0000142552_77473_7d crossref_primary_10_3748_wjg_14_2818 crossref_primary_10_1097_SLA_0b013e318148566 crossref_primary_10_1007_s00268_007_9193_1 crossref_primary_10_1097_CCE_0000000000000433 crossref_primary_10_1097_01_shk_0000144134_03598_c5 crossref_primary_10_3390_v15122354 crossref_primary_10_4037_ajcc2013225 crossref_primary_10_1345_aph_1Q319 crossref_primary_10_1007_BF02738619 crossref_primary_10_4266_kjccm_2009_24_1_28 crossref_primary_10_1016_j_ijdevneu_2018_07_012 crossref_primary_10_1007_s11845_019_02162_w crossref_primary_10_1089_sur_2012_211 crossref_primary_10_3389_fimmu_2021_706583 crossref_primary_10_1097_01_shk_0000183388_90895_cb crossref_primary_10_1152_ajplung_00123_2021 crossref_primary_10_1097_TA_0000000000001157 crossref_primary_10_1016_j_jcrc_2018_10_017 crossref_primary_10_1007_s00540_012_1425_3 crossref_primary_10_1042_CS20140840 crossref_primary_10_1152_physrev_00037_2012 crossref_primary_10_1902_jop_2010_100045 crossref_primary_10_3109_14767058_2012_684165 crossref_primary_10_1016_j_burns_2009_06_212 crossref_primary_10_1097_CM9_0000000000000392 crossref_primary_10_3748_wjg_15_5604 crossref_primary_10_15406_ghoa_2018_09_00306 crossref_primary_10_3389_fendo_2023_1152634 crossref_primary_10_1590_1519_6984_249125 crossref_primary_10_1017_S031716710005335X crossref_primary_10_1177_11297298231225808 crossref_primary_10_1016_j_jss_2005_04_015 crossref_primary_10_1016_j_surg_2003_08_012 crossref_primary_10_3390_jcm8081263 crossref_primary_10_1007_s10354_020_00787_6 crossref_primary_10_1093_cid_civ576 crossref_primary_10_1016_j_jss_2005_04_017 crossref_primary_10_1097_00024382_200207000_00005 crossref_primary_10_5812_traumamon_38083 crossref_primary_10_1016_j_autrev_2011_12_004 crossref_primary_10_1210_en_2009_0098 crossref_primary_10_1097_00024382_200210000_00004 crossref_primary_10_1167_iovs_61_14_5 crossref_primary_10_1016_j_jss_2004_12_009 crossref_primary_10_1089_109629601317202713 crossref_primary_10_1016_j_jcrc_2019_11_002 crossref_primary_10_1080_23744235_2018_1511056 crossref_primary_10_1097_CCM_0b013e318186f556 crossref_primary_10_1097_01_CCM_0000256845_92640_38 crossref_primary_10_4103_0972_5229_56052 crossref_primary_10_1016_j_jneuroim_2008_08_005 crossref_primary_10_1016_j_jcrc_2014_01_002 crossref_primary_10_1002_jor_25116 crossref_primary_10_2217_17410541_5_3_249 crossref_primary_10_1016_j_pupt_2011_07_002 crossref_primary_10_1097_01_shk_0000232589_39001_4d crossref_primary_10_1007_s12630_011_9629_9 crossref_primary_10_1016_S0899_5885_02_00028_X crossref_primary_10_1097_CCM_0b013e3182a84a43 crossref_primary_10_1097_CCM_0b013e3181760c14 crossref_primary_10_3892_mmr_2016_5112 crossref_primary_10_1177_1538574411403167 crossref_primary_10_1007_s00134_008_1313_3 crossref_primary_10_1155_2011_819724 crossref_primary_10_1128_IAI_72_7_4282_4285_2004 crossref_primary_10_1016_j_jri_2006_01_004 crossref_primary_10_1155_2017_5216562 crossref_primary_10_1080_09712119_2014_883318 crossref_primary_10_1186_s12873_024_00934_x crossref_primary_10_1016_j_jcrc_2022_153985 crossref_primary_10_7759_cureus_12844 crossref_primary_10_1155_2013_928290 crossref_primary_10_1186_s40560_016_0205_9 crossref_primary_10_1373_clinchem_2004_032144 crossref_primary_10_1016_S0002_9610_00_00298_1 crossref_primary_10_1186_s12929_024_01043_4 crossref_primary_10_1177_1099800404263014 crossref_primary_10_1371_journal_pone_0224278 crossref_primary_10_1097_PCC_0b013e31823c980f crossref_primary_10_1016_j_imlet_2019_01_002 crossref_primary_10_1016_j_jss_2008_08_035 crossref_primary_10_1186_s13293_023_00501_2 crossref_primary_10_1517_14728222_2015_1057570 crossref_primary_10_1016_j_bbi_2021_11_007 crossref_primary_10_1053_jvet_2002_34661 crossref_primary_10_1007_s00540_012_1426_2 crossref_primary_10_1097_01_CCM_0000262946_68003_21 crossref_primary_10_1371_journal_pone_0251317 crossref_primary_10_1164_rccm_200603_341OC crossref_primary_10_3390_jcm9072287 crossref_primary_10_1097_SHK_0000000000000939 crossref_primary_10_3389_fpubh_2020_00418 crossref_primary_10_1155_2018_6964529 crossref_primary_10_1016_j_jiac_2015_11_007 crossref_primary_10_1093_jn_134_10_2768S crossref_primary_10_1016_j_amjsurg_2003_07_022 crossref_primary_10_1097_SLA_0000000000000789 crossref_primary_10_1002_bies_201100047 crossref_primary_10_1089_ars_2021_0056 crossref_primary_10_1590_S1807_59322006000500017 crossref_primary_10_1667_RR1295_1 crossref_primary_10_1097_TA_0b013e31822c0d31 crossref_primary_10_1089_sur_2007_037 crossref_primary_10_1097_00001503_199904000_00003 crossref_primary_10_1097_HP_0b013e31824 crossref_primary_10_1016_S0025_7125_05_70157_7 crossref_primary_10_1016_S1550_8579_05_80007_5 crossref_primary_10_3389_fimmu_2024_1379754 crossref_primary_10_1002_emmm_201201375 crossref_primary_10_1182_blood_2003_02_0649 crossref_primary_10_1152_ajpcell_00134_2022 crossref_primary_10_1016_S0092_8674_04_00131_X crossref_primary_10_1097_00003246_200107000_00002 crossref_primary_10_1002_crt2_9 crossref_primary_10_1016_j_fsi_2016_11_057 crossref_primary_10_4103_jiaps_jiaps_156_21 crossref_primary_10_3390_ijms23169312 crossref_primary_10_1016_j_bbi_2009_02_019 crossref_primary_10_1590_S0102_86502004000200006 crossref_primary_10_1016_j_jss_2005_02_019 crossref_primary_10_1097_00005373_200211000_00013 crossref_primary_10_1097_00024382_200301000_00006 crossref_primary_10_1152_ajpgi_00036_2004 crossref_primary_10_4236_ss_2020_1111038 crossref_primary_10_1152_japplphysiol_00182_2003 crossref_primary_10_1016_j_injury_2014_08_013 crossref_primary_10_1038_sj_bjc_6601541 crossref_primary_10_3390_ijerph19158895 crossref_primary_10_1097_SHK_0b013e3182571e46 crossref_primary_10_1097_01_CCM_0000190242_24410_17 crossref_primary_10_1016_S0031_9384_01_00569_8 crossref_primary_10_1097_shk_0b013e31805cdc96 crossref_primary_10_1164_rccm_200207_682OC crossref_primary_10_1016_j_jneuroim_2013_05_004 crossref_primary_10_1164_rccm_200404_446OC crossref_primary_10_1093_jn_nxaa318 crossref_primary_10_1007_s11884_015_0301_z crossref_primary_10_1016_j_archoralbio_2010_09_008 crossref_primary_10_1097_01_CCM_0000292015_16171_6D crossref_primary_10_1152_ajpregu_00605_2005 crossref_primary_10_1016_j_ccc_2005_08_005 crossref_primary_10_1016_j_surg_2004_04_037 crossref_primary_10_1038_s41598_022_23443_y crossref_primary_10_1186_s13104_019_4353_6 crossref_primary_10_3109_03009734_2012_703255 crossref_primary_10_1007_s00423_007_0152_y crossref_primary_10_1016_S0002_9610_01_00582_7 crossref_primary_10_1097_ACO_0b013e32835d7160 crossref_primary_10_1152_ajpendo_00485_2004 crossref_primary_10_1016_j_alcohol_2004_05_005 crossref_primary_10_1016_j_fjs_2012_10_003 crossref_primary_10_1097_00003246_200203000_00028 crossref_primary_10_1016_j_urology_2014_11_025 crossref_primary_10_1016_S0300_8932_10_70281_5 crossref_primary_10_1371_journal_pone_0051457 crossref_primary_10_2147_JIR_S335203 crossref_primary_10_1097_01_CCM_0000253810_08230_83 crossref_primary_10_1016_j_amjsurg_2005_03_031 crossref_primary_10_4236_ojim_2015_53008 crossref_primary_10_1378_chest_07_0420 crossref_primary_10_1016_j_psychres_2017_05_022 crossref_primary_10_1080_00365540600993285 crossref_primary_10_1111_j_1582_4934_2009_00669_x crossref_primary_10_1177_1754073917709940 |
ContentType | Journal Article |
Copyright | Copyright American Medical Association Nov 1998 |
Copyright_xml | – notice: Copyright American Medical Association Nov 1998 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION K9. NAPCQ 7X8 |
DOI | 10.1001/archsurg.133.11.1200 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1538-3644 2168-6262 |
EndPage | 1205 |
ExternalDocumentID | 35897431 10_1001_archsurg_133_11_1200 9820351 211838 |
Genre | Journal Article Comparative Study |
GroupedDBID | --- -QF .55 .XZ 23N 2WC 354 39C 3O- 4.4 53G 5GY 6J9 AAWTL AAYEP ABCQX ABJNI ABOCM ACGFO ACGFS ADBBV AFFNX ALMA_UNASSIGNED_HOLDINGS AMJDE ARBJA BRYMA C1A C45 CS3 EAM EBS EJD EMOBN EX3 F5P GX1 IH2 J5H L7B N4W N9A OB2 OBH OHH OVD P2P RAJ RXW SJN SV3 TEORI VVN WH7 WOW X6Y X7M XHN YOC ZA5 ZE2 ZGI ZXP ZY1 2CT AI. CGR CUY CVF ECM EIF NPM RWL TAE VH1 AAYXX CITATION K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-a393t-1dc5af1c829e62d54499e650d4a29df85766f05d58f9b379be42ecc7a5829503 |
ISSN | 0004-0010 2168-6254 |
IngestDate | Sat Aug 17 01:17:53 EDT 2024 Thu Oct 10 18:38:34 EDT 2024 Fri Aug 23 04:07:45 EDT 2024 Sat Sep 28 08:36:16 EDT 2024 Fri Jul 05 02:03:44 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 11 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a393t-1dc5af1c829e62d54499e650d4a29df85766f05d58f9b379be42ecc7a5829503 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doi.org/10.1001/archsurg.133.11.1200 |
PMID | 9820351 |
PQID | 232557787 |
PQPubID | 42213 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_70074731 proquest_journals_232557787 crossref_primary_10_1001_archsurg_133_11_1200 pubmed_primary_9820351 ama_primary_211838 |
PublicationCentury | 1900 |
PublicationDate | 1998-11-01 |
PublicationDateYYYYMMDD | 1998-11-01 |
PublicationDate_xml | – month: 11 year: 1998 text: 1998-11-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Chicago |
PublicationTitle | Archives of surgery (Chicago. 1960) |
PublicationTitleAlternate | Arch Surg |
PublicationYear | 1998 |
Publisher | American Medical Association |
Publisher_xml | – name: American Medical Association |
References | 10896386 - Arch Surg. 2000 Jul;135(7):875 |
References_xml | |
SSID | ssj0012892 |
Score | 1.8106261 |
Snippet | BACKGROUND In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to... In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to sepsis in... BACKGROUND: In animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to... BACKGROUNDIn animal studies, gender differences were related to hormonal and immunologic changes that were associated with an increased susceptibility to... |
SourceID | proquest crossref pubmed ama |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1200 |
SubjectTerms | APACHE Estradiol - blood Female Hospital Mortality Humans Interleukin-10 - blood Interleukin-6 - blood Male Middle Aged Multiple Organ Failure - etiology Postoperative Complications - blood Postoperative Complications - immunology Prognosis Prospective Studies Sepsis - blood Sepsis - complications Sepsis - immunology Sex Characteristics Survival Analysis Testosterone - blood Tumor Necrosis Factor-alpha - metabolism |
Title | Gender Differences in Human Sepsis |
URI | http://dx.doi.org/10.1001/archsurg.133.11.1200 https://www.ncbi.nlm.nih.gov/pubmed/9820351 https://www.proquest.com/docview/232557787 https://search.proquest.com/docview/70074731 |
Volume | 133 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLfKuHBBTDBRNiBC3FBKHcf5OCK0UU1jHMhQxcWyHVubNCVT01721_NLnLjpNhBwiSK7deT3nn9-z34fhLxXxmqo3Ta0OZ-HQMk0lIzpkGqdKcBhGas23vnrebK4iE-XfDmZ3I6jS9Zqpm8fjCv5H66iDXxto2T_gbN-UDTgHfzFExzG86947OrA-SInzrmqL7vXmJvmqhnrnuMks42Lhu7ucJ0zxuwDVsl8dDDwXV-u6tJx9LTu82C10Cwvr51Hz48aL6tt--o6XLRAX3VVgTdKan_W_FMq5w6w9Qcufewd3TlquHeHdFeCOtiKaJKFsKrcMYEZt93BXZcBYxAwOoJR6tKX3sd3V1egC9oBnWYYApg_G36-m077_Js4uTg7E8Xxstjtdds3z_JWfXpEHkcAqRYdvyy9exC27a6gtp-ND7ukHx_6_DhR76Dc_MZi6TSX4hl52pscwScnP_tkYqrn5J2TnWAkO8FVFXSyEzjZeUGKk-Pi8yLs62VgeeVsHdJSc2mpzqLcJFHJY1izBhp4GcsoL20G0zKxc17yzOaKpbkycYQVnEqOf_A5OyB7VV2ZlySgqUYf03EmZWxsrGLLoItDPSyptImZkn3MVty4hCgigpXKsikJh8n7HpcUm4qBZAIkg9EpWpJNyeFAIdEvqkZAwec8xS4yJW99LxCvvcaSlak3jUi7og-MTsmBI6v_Wg51lnH66o8DH5InW9k-Invr1ca8hmK5Vm86CfgFA3F12A |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gender+differences+in+human+sepsis&rft.jtitle=Archives+of+surgery+%28Chicago.+1960%29&rft.au=Schroder%2C+Jorg&rft.au=Kahlke%2C+Volker&rft.au=Karl-Hermann+Staubach&rft.au=Zabel%2C+Peter&rft.date=1998-11-01&rft.pub=American+Medical+Association&rft.issn=2168-6254&rft.eissn=2168-6262&rft.volume=133&rft.issue=11&rft.spage=1200&rft_id=info:doi/10.1001%2Farchsurg.133.11.1200&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=35897431 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-0010&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-0010&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-0010&client=summon |